Antiviral therapy in chronic hepatitis B remains a problem Newsletter Article 20 February 2013 Pages: 2 - 2
Why do antihypertensives offer limited protection against coronary heart disease? Newsletter Article 20 February 2013 Pages: 2 - 3
Problems in prophylaxis - control of oesophageal varices Newsletter Article 20 February 2013 Pages: 3 - 3
Does nifedipine protect against cyclosporin-induced nephrotoxicity? Newsletter Article 20 February 2013 Pages: 3 - 3
Conservative management of asymptomatic gallstones is recommended Newsletter Article 20 February 2013 Pages: 3 - 4
Loratadine: does not affect sleep latency and produces less performance impairment than diphenhydramine Newsletter Article 20 February 2013 Pages: 4 - 4
Iloprost: shows prolonged vascular benefits in patients with Raynaud's phenomenon secondary to systemic sclerosis Newsletter Article 20 February 2013 Pages: 4 - 4
Mitoxantrone Combinations Have High Patient Acceptability Newsletter Article 20 February 2013 Pages: 5 - 6
IV Methylprednisolone is Beneficial in Paediatric Status Asthmaticus Newsletter Article 20 February 2013 Pages: 6 - 6
A Well-Tolerated Alternative in Minor Sports Injuries Newsletter Article 20 February 2013 Pages: 6 - 6
A Once-Daily β-Blocker is a Useful Addition to Antiarrhythmic Therapy Newsletter Article 20 February 2013 Pages: 6 - 7
Propranolol Appears to Decrease the Bleeding Rate and Mortality Newsletter Article 20 February 2013 Pages: 7 - 8
IV Streptokinase Improves LV Function and Short Term Survival Newsletter Article 20 February 2013 Pages: 8 - 8
Ticarcillin/Clavulanic Acid Is Comparable to Cefotaxime Newsletter Article 20 February 2013 Pages: 9 - 9
Antiplatelet Therapy Reduces the Incidence of Thrombosis Newsletter Article 20 February 2013 Pages: 9 - 9
Three Key Issues in Antihypertensive Therapy (continued from last week) Newsletter Article 20 February 2013 Pages: 10 - 10
Moracizine Monotherapy Suppresses PVCs, Couplets and Runs Newsletter Article 20 February 2013 Pages: 10 - 11
Passive Immunisation Reduces Invasive Infections in Infants Newsletter Article 20 February 2013 Pages: 11 - 11
High Dose Moracizine is a Promising Antiarrhythmic Treatment Newsletter Article 20 February 2013 Pages: 12 - 12
Continuous Insulin Infusion Causes Initial Progression in Retinopathy Newsletter Article 20 February 2013 Pages: 12 - 12
Obsessive-Compulsive Symptoms Show Little Response to Imipramine Newsletter Article 20 February 2013 Pages: 13 - 13
Atenolol Reduces Ischaemic Episodes in Mixed Angina Newsletter Article 20 February 2013 Pages: 13 - 13
Nadolol and Atenolol Suppress Some Supraventricular Tachycardias Newsletter Article 20 February 2013 Pages: 14 - 14
Verapamil has Similar Short Term Anti-Ischaemic Efficacy to Atenolol Newsletter Article 20 February 2013 Pages: 14 - 14
Sodium Supplements Decrease the Nephrotoxicity of Amphotericin B Newsletter Article 20 February 2013 Pages: 14 - 15
β-Blockers Reduce Stress-Induced Increases in Cardiac Workload Newsletter Article 20 February 2013 Pages: 15 - 16
Cefminox: launched in Japan by Meiji Seika and Bristol-Myers - its world first introduction (continued) Newsletter Article 20 February 2013 Pages: 19 - 19